In Delhi, a city of millions, the thin line between a dog bite and a death sentence has grown thinner still. Municipal hospitals across the capital have nearly exhausted their anti-rabies vaccine stocks — some, like Hindu Rao, have had none for four months — even as bite cases rise and the disease they prevent remains almost universally fatal once symptoms emerge. The crisis exposes not merely a supply failure but a deeper fracture in the architecture of public health: the gap between what a city promises its people and what it can actually deliver when it matters most.
Delhi hospitals face critical anti-rabies vaccine shortage amid rising dog bite cases
Rising dog bite cases in Delhi region lack adequate vaccine access, potentially exposing patients to rabies infection risk.
The vaccine has been absent for three to four years
Mark
So Hindu Rao hasn't had the vaccine in four months—how does a major hospital just run out and stay empty that long?
Mimi
Because they don't buy it themselves. The public health department is supposed to supply it. When that supply breaks down, the hospital has no independent way to fix it.
Luke
Do we know why the supply broke down? Is it a budget issue, a procurement delay, a miscalculation of demand?
Mimi
The reporting doesn't say. We know a tender was floated to buy 30,000 doses, but we don't know what caused the initial failure.
Mark
And patients are just being sent elsewhere?
Mimi
Yes. Hindu Rao sends them to MVID. Kasturba has been doing this for years—sending people to Lady Hardinge or Ram Manohar Lohia. It works if those hospitals have stock, but MVID itself is running low on the actual vaccine.
Luke
How low is low? The story says MVID has serum but fewer rabipur doses. That's vague. We don't know if they're turning people away or if they can still treat everyone.
Mark
And the 30,000 doses the MCD is procuring—when will those arrive?
Mimi
The story doesn't say. It just says the tender was floated. Procurement can take weeks or months.
Luke
So right now, in September 2022, there's a real gap. Dog bites are rising, and the system is fragmented and understocked. That's the story.
Mark
What about the pet registration push? Does that actually reduce bites?
Mimi
It could, but most bites in Delhi come from strays, which can't be registered. It's a partial solution to a larger problem.
Luke
The story doesn't give us numbers on how many bites are happening or how many people are being turned away. We know the shortage exists, but we don't know the human impact yet.
Il Polso
- With only 5,000 doses left across all MCD hospitals and Hindu Rao empty for four months, Delhi's anti-rabies supply has effectively collapsed under rising demand.
- Bite victims are being shuttled between facilities in a city-wide referral chain, losing precious time in the narrow window when post-exposure treatment can still save a life.
- Even the specialized overflow hospital, MVID, is running low on rabipur — the full vaccine course — leaving patients with only temporary serum protection and no guarantee of follow-through.
- Some hospitals, like Kasturba, have quietly normalized the shortage over years, routinely sending patients to institutions outside the MCD system as if the gap were simply policy.
- The MCD has floated a tender for 30,000 doses, but procurement moves on bureaucratic time while dog bites arrive on human time — and the distance between those two rhythms is where lives are at risk.
In Delhi, a city of millions, the thin line between a dog bite and a death sentence has grown thinner still. Municipal hospitals across the capital have nearly exhausted their anti-rabies vaccine stocks — some, like Hindu Rao, have had none for four months — even as bite cases rise and the disease they prevent remains almost universally fatal once symptoms emerge. The crisis exposes not merely a supply failure but a deeper fracture in the architecture of public health: the gap between what a city promises its people and what it can actually deliver when it matters most.
Delhi's municipal hospitals are nearly out of anti-rabies vaccine at the very moment dog bite cases are climbing across the capital. Hindu Rao Hospital, one of the city's major public institutions, has had zero doses for four months. Across the MCD hospital network, only 5,000 doses remain — a number that shrinks daily against rising need.
The shortage has produced a geography of desperation. Patients at Hindu Rao are redirected to Maharishi Valmiki Infectious Disease Hospital, the specialized facility meant to absorb the overflow. But MVID itself is running low on rabipur, the vaccine formulation that provides lasting immunity. Anti-rabies serum — a stopgap that offers immediate but incomplete protection — remains available, yet without the follow-up vaccine course, patients are left vulnerable.
Kasturba Hospital tells a quieter, more troubling story: the vaccine has been absent there for three to four years. Staff have long since normalized the practice of sending patients to Lady Hardinge or Ram Manohar Lohia, hospitals outside the MCD system entirely. At Rajan Babu, the same pattern holds. Swami Dayanand is among the rare exceptions with stock on hand, though even its administrators have requested more.
The structural failure is clear. Hindu Rao does not procure its own vaccines — the public health department is meant to supply them, and that supply has broken down. The MCD, aware of the crisis, has floated a tender for 30,000 doses to be distributed across major hospitals and polyclinics. But procurement takes time that bite victims do not have.
The city has also moved to require pet registration and warn owners of consequences for non-compliance — a reasonable measure, but one that cannot reach Delhi's vast stray dog population. Prevention is incomplete, treatment capacity is compromised, and for patients arriving at these hospitals with fresh wounds and a fatal disease on the clock, the distance between what should exist and what does has become the difference between life and death.
Delhi's municipal hospitals are running on fumes. As dog bite cases climb across the capital and its surrounding region, the facilities meant to treat them are nearly out of the vaccine that prevents rabies—a disease that, once symptoms appear, is almost always fatal. Hindu Rao Hospital, one of the city's major public institutions, has not had a single dose of anti-rabies vaccine for four months. The broader picture is just as grim: across the network of MCD-run hospitals, only 5,000 doses remain in stock.
The shortage has forced a system of triage by geography and availability. Patients arriving at Hindu Rao seeking post-exposure prophylaxis are redirected to Maharishi Valmiki Infectious Disease Hospital, which sits closer to some parts of the city. But even MVID, the specialized facility meant to absorb this overflow, is running low on the specific vaccine formulation—rabipur—that provides lasting immunity. The anti-rabies serum, which offers immediate protection in the critical window after a bite, remains available there, but it is only a temporary measure. Without the vaccine course that follows, protection is incomplete.
Kasturba Hospital tells a longer story of neglect. Doctors there report the vaccine has been absent for three to four years. Staff have grown accustomed to sending patients elsewhere—to Lady Hardinge Medical College or Ram Manohar Lohia Hospital, institutions outside the MCD system. At Rajan Babu Hospital, the same referral pattern holds: patients go to MVID because proximity matters when someone has just been bitten and needs immediate care. Swami Dayanand Hospital is among the few with stock on hand, though even there, administrators have requested additional supplies from above.
The root of the problem is structural. Hindu Rao's senior doctors explain that the hospital does not procure its own vaccines. The public health department is supposed to supply them. That supply has failed. The Municipal Corporation of Delhi, meanwhile, has been aware of the crisis long enough to act: a tender has been floated to purchase 30,000 doses, which will be distributed to major MCD hospitals and select polyclinics once the procurement process clears. But procurement takes time, and dog bites do not wait.
The MCD has also moved on a separate front, asking residents to register their pets and warning of action against those who do not comply. The logic is sound—fewer unvaccinated dogs means fewer bites. But the city's stray dog population, which accounts for a significant share of incidents, cannot be registered or easily controlled. The vaccine shortage arrives at a moment when prevention through animal control is incomplete and treatment capacity is compromised. For patients arriving at these hospitals with fresh bites and the clock ticking, the gap between what should be available and what actually is has become a matter of life and death.
Citazioni salienti
The institution does not purchase anti-rabies vaccine on its own but is provided by the public health department— Senior doctor at Hindu Rao Hospital
We have not had the anti-rabies vaccine in a long time. It's been 3-4 years, and we have been referring our patients to either Lady Hardinge or Ram Manohar Lohia hospitals— Doctor at Kasturba Hospital
Vuoi la storia completa?
Leggi l'originale su The Indian Express ↗
Health & Medicine